Get started
Author

Kurt Segers

WT1 MUTATION IN MALIGNANT MESOTHELIOMA AND WT1 IMMUNOREACTIVITY IN RELATION TO p53 AND GROWTH FACTOR RECEPTOR EXPRESSION, CELL‐TYPE TRANSITION, AND PROGNOSIS
1997 · SAMIR KUMAR-SINGH, KURT SEGERS, et al. · The Journal of Pathology · 124
Evaluation of Tumour Angiogenesis as a Prognostic Marker in Malignant Mesothelioma
1997 · SAMIR KUMAR-SINGH, PETER B. VERMEULEN, et al. · The Journal of Pathology · 84
Performance of middle-aged and elderly European minority and majority populations on a Cross-Cultural Neuropsychological Test Battery (CNTB)
2018 · T. Rune Nielsen, Kurt Segers, et al. · The Clinical Neuropsychologist · 79
P16INK4a as an adjunct marker in liquid‐based cervical cytology
2004 · Shaira Sahebali, Christophe E. Depuydt, et al. · International Journal of Cancer · 68
Validation of a European Cross‐Cultural Neuropsychological Test Battery (CNTB) for evaluation of dementia
2018 · T. Rune Nielsen, Kurt Segers, et al. · International Journal of Geriatric Psychiatry · 58
Immunoreactivity for bcl-2 protein in malignant mesothelioma and non-neoplastic mesothelium
1994 · K. Segers, M. Ramael, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 48
Thin-layer liquid-based cervical cytology and PCR for detecting and typing human papillomavirus DNA in Flemish women
2003 · C E Depuydt, A J Vereecken, et al. · British Journal of Cancer · 44
PDF
Novel SACS mutation in a Belgian family with sacsin-related ataxia
2007 · Y. Ouyang, K. Segers, et al. · Journal of the Neurological Sciences · 41
Pioneers in migration, pioneering in dementia: first generation immigrants in a European metropolitan memory clinic
2013 · Kurt Segers, Florence Benoit, et al. · Acta Neurologica Belgica · 40
Degenerative Dementias and Their Medical Care in the Movies
2007 · Kurt Segers · Alzheimer Disease & Associated Disorders · 38
Validation of the Rowland Universal Dementia Assessment Scale (RUDAS) in a multicultural sample across five Western European countries: diagnostic accuracy and normative data
2018 · T. Rune Nielsen, Kurt Segers, et al. · International Psychogeriatrics · 34
Immunohistochemical distribution patterns of epidermal growth factor receptor in malignant mesothelioma and non-neoplastic mesothelium
1991 · Marc Ramael, Kurt Segers, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 34
Immunoreactivity for the β chain of the platelet‐derived growth factor receptor in malignant mesothelioma and non‐neoplastic mesothelium
1992 · Marc Ramael, Corinne Buysse, et al. · The Journal of Pathology · 32
Validation of a brief Multicultural Cognitive Examination (MCE) for evaluation of dementia
2019 · T. Rune Nielsen, Kurt Segers, et al. · International Journal of Geriatric Psychiatry · 29
Immunoreactivity for p53 and mdm2 and the detection of p53 mutations in human malignant mesothelioma
1995 · K. Segers, S. K. Singh, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 28
Anxiety symptoms are quantitatively and qualitatively different in dementia with Lewy bodies than in Alzheimerʼs disease in the years preceding clinical diagnosis
2019 · Kurt Segers, Florence Benoit, et al. · Psychogeriatrics · 27
A Retrospective Belgian Multi-Center MRI Biomarker Study in Alzheimer’s Disease (REMEMBER)
2018 · Ellis Niemantsverdriet, Annemie Ribbens, et al. · Journal of Alzheimer s Disease · 26
PDF
What Belgian Neurologists and Neuropsychiatrists Tell Their Patients With Alzheimer Disease and Why
2009 · Meriem Essabiri Tarek, Kurt Segers, et al. · Alzheimer Disease & Associated Disorders · 26
Immunoreactivity for p‐170 glycoprotein in malignant mesothelioma and in non‐neoplastic mesothelium of the pleura using the murine monoclonal antibody JSB‐1
1992 · Marc Ramael, Jan Van Den Bossche, et al. · The Journal of Pathology · 26
Diagnostic Performance of Automated MRI Volumetry by icobrain dm for Alzheimer’s Disease in a Clinical Setting: A REMEMBER Study
2021 · Mandy Melissa Jane Wittens, Diana Maria Sima, et al. · Journal of Alzheimer s Disease · 23
PDF
Brain age as a biomarker for pathological versus healthy ageing – a REMEMBER study
2024 · Mandy M.J. Wittens, Stijn Denissen, et al. · Alzheimer s Research & Therapy · 20
PDF
Dementia, End of Life, and Euthanasia: A Survey Among Dementia Specialists Organized by the Belgian Dementia Council
2019 · Gaëtane Picard, Jean-Christophe Bier, et al. · Journal of Alzheimer s Disease · 19
Dramatic Response to First Line Single Agent Pembrolizumab in Anaplastic Thyroid Carcinoma
2019 · Valérie Spalart, Barbara Legius, et al. · Case Reports in Endocrinology · 18
PDF
Immunoreactivity for c-fos and c-myc protein with the monoclonal antibodies 14E10 and 6E10 in malignant mesothelioma and non-neoplastic mesothelium of the pleura.
1995 · M Ramael, J Van den Bossche, et al. · PubMed · 17
Adult Polyglucosan Body Disease Masquerading as “ALS With Dementia of the Alzheimer Type”
2011 · Kurt Segers, Hazim Kadhim, et al. · Alzheimer Disease & Associated Disorders · 16
Works count: 84
Citation count: 1,191
H-index: 20
I10-index: 31
Year
Topic
Type